BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17617292)

  • 1. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of the serotonin transporter and associations with antidepressant response.
    Kraft JB; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter gene and response to lithium augmentation in depression.
    Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M
    Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticipated outcomes from introduction of 5-HTTLPR genotyping for depressed patients: an expert Delphi analysis.
    Oestergaard S; Møldrup C
    Public Health Genomics; 2010; 13(7-8):406-14. PubMed ID: 20606382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HTTLPR modulates antidepressant efficacy in depressed women.
    Gressier F; Bouaziz E; Verstuyft C; Hardy P; Becquemont L; Corruble E
    Psychiatr Genet; 2009 Aug; 19(4):195-200. PubMed ID: 19451862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA; Esdaile JM; Anis AH
    J Rheumatol; 2002 Dec; 29(12):2507-12. PubMed ID: 12465143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics; 2006 Mar; 7(2):159-66. PubMed ID: 16515395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
    Ferreira Ade A; Neves FS; da Rocha FF; Silva GS; Romano-Silva MA; Miranda DM; De Marco L; Correa H
    J Affect Disord; 2009 Jan; 112(1-3):267-72. PubMed ID: 18534687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries.
    Olgiati P; Bajo E; Bigelli M; De Ronchi D; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):147-54. PubMed ID: 21911028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.
    Serretti A; Olgiati P; Bajo E; Bigelli M; De Ronchi D
    World J Biol Psychiatry; 2011 Oct; 12(7):501-15. PubMed ID: 21595526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural and genetic correlates of antidepressant response to sleep deprivation: a functional magnetic resonance imaging study of moral valence decision in bipolar depression.
    Benedetti F; Bernasconi A; Blasi V; Cadioli M; Colombo C; Falini A; Lorenzi C; Radaelli D; Scotti G; Smeraldi E
    Arch Gen Psychiatry; 2007 Feb; 64(2):179-87. PubMed ID: 17283285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
    Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Anton SF; Revicki DA
    Psychopharmacol Bull; 1995; 31(2):249-58. PubMed ID: 7491376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.